Literature DB >> 32090770

Neuroanatomical predictors of L-DOPA response in older adults with psychomotor slowing and depression: A pilot study.

Bret R Rutherford1, Jongwoo Choi2, Mark Slifstein3, Kaleigh O'Boyle2, Anissa Abi-Dargham3, Patrick J Brown2, Melanie W Wall2, Nora Vanegas-Arroyave4, Jayant Sakhardande4, Yaakov Stern4, Steven P Roose2.   

Abstract

BACKGROUND: Declining function in dopamine circuits is implicated in normal aging and late-life depression (LLD). Dopamine augmentation recently has shown therapeutic promise, but predictors of response are unknown.
METHODS: Depressed elders with slowed gait underwent baseline magnetic resonance imaging (MRI) and [11C]raclopride positron emission tomography (PET). Subjects then received open treatment with carbidopa/levodopa (L-DOPA) for three weeks. Linear regressions examined relationships between baseline MRI measures, [11C]raclopride binding, and behavioral outcomes.
RESULTS: Among N = 16 participants aged 72.5 ± 6.8 years, higher left superior temporal gyrus volume was associated with higher processing speed at baseline, while cortical thinning in a processing speed network was associated with greater improvement following L-DOPA. Greater volume and cortical thickness in brain regions associated with mobility were associated with higher baseline gait speed. Higher baseline white matter hyperintensity volume predicted less post-L-DOPA improvement on dual task gait speed and IDS-SR scores. Higher [11C]raclopride binding in the associative striatum was associated with cortical thickness in some, but not all, processing speed brain regions, while higher binding in sensorimotor striatum was significantly associated with left caudate volume. LIMITATIONS: Limiting the conclusions drawn from this pilot study are the small sample size and open administration of L-DOPA.
CONCLUSIONS: Greater baseline brain volumes and cortical thickness in regions supporting cognition and gait were associated with higher behavioral performance, while lower structural integrity was associated with increased responsivity to L-DOPA. If substantiated in larger studies, these findings could facilitate the targeting of dopaminergic treatments to those LLD patients most likely to respond.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Gait speed; Late life depression; Levodopa; Magnetic resonance imaging; Processing speed

Mesh:

Substances:

Year:  2020        PMID: 32090770      PMCID: PMC7042346          DOI: 10.1016/j.jad.2020.01.066

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  32 in total

Review 1.  NIH consensus conference. Diagnosis and treatment of depression in late life.

Authors: 
Journal:  JAMA       Date:  1992-08-26       Impact factor: 56.272

Review 2.  Executive dysfunction and treatment response in late-life depression.

Authors:  Monique A Pimontel; Michelle E Culang-Reinlieb; Sarah S Morimoto; Joel R Sneed
Journal:  Int J Geriatr Psychiatry       Date:  2011-10-18       Impact factor: 3.485

Review 3.  Design makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depression.

Authors:  Joel R Sneed; Bret R Rutherford; David Rindskopf; David T Lane; Harold A Sackeim; Steven P Roose
Journal:  Am J Geriatr Psychiatry       Date:  2007-11-12       Impact factor: 4.105

4.  An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest.

Authors:  Rahul S Desikan; Florent Ségonne; Bruce Fischl; Brian T Quinn; Bradford C Dickerson; Deborah Blacker; Randy L Buckner; Anders M Dale; R Paul Maguire; Bradley T Hyman; Marilyn S Albert; Ronald J Killiany
Journal:  Neuroimage       Date:  2006-03-10       Impact factor: 6.556

5.  Effects of L-DOPA Monotherapy on Psychomotor Speed and [11C]Raclopride Binding in High-Risk Older Adults With Depression.

Authors:  Bret R Rutherford; Mark Slifstein; Chen Chen; Anissa Abi-Dargham; Patrick J Brown; Melanie W Wall; Nora Vanegas-Arroyave; Yaakov Stern; Veronika Bailey; Emily Valente; Steven P Roose
Journal:  Biol Psychiatry       Date:  2019-04-15       Impact factor: 13.382

6.  Inflammation, Depression, and Slow Gait: A High Mortality Phenotype in Later Life.

Authors:  Patrick J Brown; Steven P Roose; Jun Zhang; Melanie Wall; Bret R Rutherford; Hilsa N Ayonayon; Meryl A Butters; Tamara Harris; Anne B Newman; Suzanne Satterfield; Eleanor M Simonsick; Kristine Yaffe
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-09-20       Impact factor: 6.053

7.  Functional connectivity associated with gait velocity during walking and walking-while-talking in aging: a resting-state fMRI study.

Authors:  Jennifer Yuan; Helena M Blumen; Joe Verghese; Roee Holtzer
Journal:  Hum Brain Mapp       Date:  2014-12-11       Impact factor: 5.038

Review 8.  The diagnosis and treatment of late-life depression.

Authors:  A J Rothschild
Journal:  J Clin Psychiatry       Date:  1996       Impact factor: 4.384

9.  Treatment course with antidepressant therapy in late-life depression.

Authors:  Yvette I Sheline; Brianne M Disabato; Jennifer Hranilovich; Carrie Morris; Gina D'Angelo; Carl Pieper; Tommaso Toffanin; Warren D Taylor; James R MacFall; Consuelo Wilkins; Deanna M Barch; Kathleen A Welsh-Bohmer; David C Steffens; Ranga R Krishnan; P Murali Doraiswamy
Journal:  Am J Psychiatry       Date:  2012-11       Impact factor: 18.112

10.  The bidirectional association between depressive symptoms and gait speed: evidence from the English Longitudinal Study of Ageing (ELSA).

Authors:  Panayotes Demakakos; Rachel Cooper; Mark Hamer; Cesar de Oliveira; Rebecca Hardy; Elizabeth Breeze
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

View more
  2 in total

1.  Is impaired dopaminergic function associated with mobility capacity in older adults?

Authors:  Simon Moskowitz; David W Russ; Leatha A Clark; Nathan P Wages; Dustin R Grooms; Adam J Woods; Julie Suhr; Janet E Simon; Andrew O'Shea; Cody R Criss; Paolo Fadda; Brian C Clark
Journal:  Geroscience       Date:  2020-11-24       Impact factor: 7.713

2.  Sarcopenia and Neuroscience: Learning to Communicate.

Authors:  Brian C Clark; Richard G Carson
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-09-13       Impact factor: 6.053

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.